Press Releases
FDA Approves Mercks KEYTRUDA® for Patients with Recurrent or Metastatic Head and Neck Cancer
Merck known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy, at a fixed dose of 200...
Press Releases
Teva Announces Launch of Generic Gleevec® Tablets in the United States
Teva Pharmaceutical Industries Ltd announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100 mg and 400 mg, in the United States for multiple indications approved by the FDA.  Teva remains committed to strengthening...
Press Releases
Momenta Discontinues Further Accrual of its Phase 2 Trial of Necuparanib
 The decision to discontinue enrollment into the study was based on the recommendation from the independent Data Safety Monitoring Board (DSMB) following a planned interim futility analysis conducted once 57 deaths (50% of the target number of...
Press Releases
Novartis CDK4/6 inhibitor LEE011 receives FDA Breakthrough Therapy designation as first-line treatment for advanced breast cancer
Novartis announced today that the US FDA has granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for the treatment of hormone receptor positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer. ...
Press Releases
Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
Amgen and Advaxis, Inc announced a global agreement for the development and commercialization of Advaxis' ADXS-NEO, a novel, preclinical investigational cancer immunotherapy treatment that is designed to activate a patient's immune system to respond against the unique mutations, or...
Press Releases
Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology
Companies plan to advance Western Oncolytics’ lead preclinical therapy into human testingPotential combination of WO-12 with Pfizer’s oncology pipeline could enhance therapeutic benefit in patients. Pfizer Inc and Western Oncolytics announced that they have entered into...
Press Releases
Economics Drives Thailand led Laboratory Market in ASEAN
Thailand, 2nd largest economy in South East Asia, promotes foreign investment with new S curve structure towards innovative, digital and research based economy, leading the country to the new dimension of laboratory, biotechnology and life science investment in ASEAN....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read